Xi S - Search Results

1

ypTNM category combined with AJCC tumor regression grade for screening patients with the worst prognosis after neoadjuvant chemoradiation therapy for locally advanced rectal cancer.

Wei J, Huang R, Guo S, Zhang X, Xi S, Wang Q, Chang H, Wang X, Xiao W, Zeng Z, Gao Y. Wei J, et al. Among authors: xi s. Cancer Manag Res. 2018 Oct 31;10:5219-5225. doi: 10.2147/CMAR.S179151. eCollection 2018. Cancer Manag Res. 2018. PMID: 30464619 Free PMC article.

2

Tumor deposits: markers of poor prognosis in patients with locally advanced rectal cancer following neoadjuvant chemoradiotherapy.

Zhang LN, Xiao WW, Xi SY, OuYang PY, You KY, Zeng ZF, Ding PR, Zhang HZ, Pan ZZ, Xu RH, Gao YH. Zhang LN, et al. Oncotarget. 2016 Feb 2;7(5):6335-44. doi: 10.18632/oncotarget.6656. Oncotarget. 2016. PMID: 26695441 Free PMC article.

3

Pathological Assessment of the AJCC Tumor Regression Grading System After Preoperative Chemoradiotherapy for Chinese Locally Advanced Rectal Cancer.

Zhang LN, Xiao WW, Xi SY, OuYang PY, You KY, Zeng ZF, Ding PR, Zhang HZ, Pan ZZ, Xu RH, Gao YH. Zhang LN, et al. Medicine (Baltimore). 2016 Jan;95(3):e2272. doi: 10.1097/MD.0000000000002272. Medicine (Baltimore). 2016. PMID: 26817863 Free PMC article.

4

Predictive value of APAF-1 and COX-2 expression in pathologic complete response to neoadjuvant chemoradiotherapy for patients with locally advanced rectal adenocarcinoma.

Peng H, You K, Zhang R, Xi S, Zhang T, Dong J, Cai M, Wang C, Zhang H, Zhou T, Gao Y, Wen B. Peng H, et al. Among authors: xi s. Oncotarget. 2016 Jun 7;7(23):35233-40. doi: 10.18632/oncotarget.9125. Oncotarget. 2016. PMID: 27153549 Free PMC article.

5

Can an IL13 -1112 C/T (rs1800925) polymorphism predict responsiveness to neoadjuvant chemoradiotherapy and survival of Chinese Han patients with locally advanced rectal cancer?

Xiao L, Yu X, Zhang R, Chang H, Xi S, Xiao W, Zeng Z, Zhang H, Xu R, Gao Y. Xiao L, et al. Among authors: xi s. Oncotarget. 2016 Jun 7;7(23):34149-57. doi: 10.18632/oncotarget.9178. Oncotarget. 2016. PMID: 27167201 Free PMC article.

6

Pathological Assessment of Rectal Cancer after Neoadjuvant Chemoradiotherapy: Distribution of Residual Cancer Cells and Accuracy of Biopsy.

Xiao L, Yu X, Deng W, Feng H, Chang H, Xiao W, Zhang H, Xi S, Liu M, Zhu Y, Gao Y. Xiao L, et al. Among authors: xi s. Sci Rep. 2016 Oct 10;6:34923. doi: 10.1038/srep34923. Sci Rep. 2016. PMID: 27721486 Free PMC article.

7

Overexpression of LAMC1 predicts poor prognosis and enhances tumor cell invasion and migration in hepatocellular carcinoma.

Zhang Y, Xi S, Chen J, Zhou D, Gao H, Zhou Z, Xu L, Chen M. Zhang Y, et al. Among authors: xi s. J Cancer. 2017 Aug 25;8(15):2992-3000. doi: 10.7150/jca.21038. eCollection 2017. J Cancer. 2017. PMID: 28928891 Free PMC article.

8

A Genotype Signature for Predicting Pathologic Complete Response in Locally Advanced Rectal Cancer.

Xiao WW, Li M, Guo ZW, Zhang R, Xi SY, Zhang XG, Li Y, Wu DQ, Ren YF, Pang XL, Wan XB, Li K, Zhou CL, Zhai XM, Liang ZK, Wang QX, Zeng ZF, Zhang HZ, Yang XX, Wu YS, Li M, Gao YH. Xiao WW, et al. Int J Radiat Oncol Biol Phys. 2021 Jun 1;110(2):482-491. doi: 10.1016/j.ijrobp.2021.01.005. Epub 2021 Jan 9. Int J Radiat Oncol Biol Phys. 2021. PMID: 33434612

9

Nomogram to Predict Distant Metastasis Probability for Pathological Complete Response Rectal Cancer Patients After Neoadjuvant Chemoradiotherapy.

Jiang T, Liu S, Wu X, Liu X, Li W, Yang S, Cai P, Xi S, Zeng Z, Gao Y, Chen G, Xiao W. Jiang T, et al. Among authors: xi s. Cancer Manag Res. 2021 Jun 15;13:4751-4761. doi: 10.2147/CMAR.S313113. eCollection 2021. Cancer Manag Res. 2021. PMID: 34163249 Free PMC article.

10

Neoadjuvant PD-1 blockade with sintilimab in mismatch-repair deficient, locally advanced rectal cancer: an open-label, single-centre phase 2 study.

Chen G, Jin Y, Guan WL, Zhang RX, Xiao WW, Cai PQ, Liu M, Lin JZ, Wang FL, Li C, Quan TT, Xi SY, Zhang HZ, Pan ZZ, Wang F, Xu RH. Chen G, et al. Lancet Gastroenterol Hepatol. 2023 May;8(5):422-431. doi: 10.1016/S2468-1253(22)00439-3. Epub 2023 Mar 1. Lancet Gastroenterol Hepatol. 2023. PMID: 36870360 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

987 results

Search Page

Filters